| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0515 | Ainsliadimer A | Natural selective inhibitor of IKKα/β by covalently binding a conserved cysteine |
|
| DCC0516 | Aip-iv | Novel quorum sensing (QS) signaling molecule produced by Staphylococcus aureusagr type IV |
|
| DCC0517 | Aiu2008 | Novel FMS-like tyrosine kinase 3 (FLT3) inhibitor, showing improved anti-leukemic efficacy in FLT3-ITD-positive AML cells, specifically inhibiting cell growth and apoptotic death, down-regulating DNA repair genes involved in homologous recombination and n |
|
| DCC0518 | Aj-108235 | Novel inhibitor of long chain fatty acid elongase 6 (ELOVL6) |
|
| DCC0519 | Aj-9677 | Novel β3-Adrenoceptor agonist, reducing body fat in obese beagles |
|
| DCC0520 | Ajh-836 | Novel protein kinase C (PKC) activator, preferentially binding to the novel PKC isoforms PKCδ and PKC∈, stimulated a striking preferential redistribution of PKC∈ to the plasma membrane relative to PKCα, inducing major changes in cytoskeletal reorganizatio |
|
| DCC0521 | Ak346zi | Novel antiproliferative agent |
|
| DCC0522 | Ak963/40708899 | Novel and potent PAK1 (p21-activated kinase 1) inhibitor, suppressing the proliferation of human gastric cancer cells significantly by downregulation of PAK1-NFκB-CyclinB1 pathway |
|
| DCC0523 | Akos024836912 | Novel Inhibitor of EGF-EGFR Interactions |
|
| DCC0524 | Akp-001 | Novel inhibitor of p38 MAP kinase |
|
| DCC0525 | Akp-11 | Novel S1P1 agonist |
|
| DCC0526 | Akr1c3-in-14a | Novel potent and selective aldo-keto reductase 1C3 inhibitor, displaying selectivity for AKR1C3 over other AKR1C enzymes and COX |
|
| DCC0527 | Akti-2 | Cell-permeable Akt1/2 inhibitor with improved solubility and Ak2 selectivity |
|
| DCC0528 | Al-34662 | Potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist |
|
| DCC0529 | Al-438 | Non-steroidal selective modulator for the glucocorticoid receptor (GR) |
|
| DCC0530 | Al-661 | Novel HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C |
|
| DCC0531 | Alalevonadifloxacin Mesylate | Novel anti-MRSA antibacterial agent, targeting infections caused by Gram-positive bacteria |
|
| DCC0532 | Ala-vpa Conjugate-1 | α-Linolenic acid-Valproic acid conjugate, not only modulating microglia polarization, but also counteracting neurodegeneration and demyelination and induce oligodendrocyte precursor cell differentiation, by acting on multiple biochemical and epigenetic pa |
|
| DCC0533 | Alazocine | Potent analgesic, psychotomimetic or hallucinogen, and morphine or opioid antagonist |
|
| DCC0534 | Albicidin | Potent DNA gyrase inhibitor |
|
| DCC0535 | Albiziabioside A | Natural antitumor agent, inducing caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway |
|
| DCC0536 | Albucidin | Novel nucleoside phytotoxin |
|
| DCC0537 | Alcuronium Chloride | Neuromuscular blocking (NMB) agent |
|
| DCC0538 | Alda-89 | Novel activator of ALDH3A1 |
|
| DCC0539 | Aldi-2 | Potent and specific covalent inhibitor of aldehyde dehydrogenases |
|
| DCC0540 | Aldi-6 Hydrochloride | Novel ALDH inhibitor, inhibiting ALDH3A1 activity in SCC4 HNSCC xenografts |
|
| DCC0541 | Aldoxorubicin | Prodrug of the anthracycline antibiotic doxorubicin, binding selectively to the cysteine-34 position of albumin via its maleimide moiety, inhibiting DNA synthesis, and inducing apoptosis |
|
| DCC0542 | Alk/ros1-in-7d | Potent and selective L1196M ALK and ROS1 dual inhibitor |
|
| DCC0543 | Alk-001 Featured | ALK-001 is a vitamin A analog potentially for the treatment of Stargardt’s disease. |
.gif)
|
| DCC0544 | Alk-gw9662 | Clickable PPARγ inhibitor |
|
